| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| 4-(3-Pyridyl)-2-chloropyrimidine |
4-(3-吡啶基)-2-氯嘧啶 |
483324-01-2 |
詳細(xì)
|
| AP20187 |
AP 20187,蛋白質(zhì)二聚化的化學(xué)誘導(dǎo)劑 |
195514-80-8 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG2-N3 |
(S,R,S)-AHPC-二聚乙二醇-疊氮 |
2010159-45-0 |
詳細(xì)
|
| (S,R,S)-AHPC-C3-NH2 |
VH032-C3-NH2 |
2361119-88-0 |
詳細(xì)
|
| (S,R,S)-AHPC-Me-C5-COOH |
7-(((S)-1-((2S,4R)-4-羥基-2-(((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)氨基甲?；?吡咯烷-1-基)-3,3-二甲基-1-氧代丁-2-基)氨基)-7-氧代庚酸 |
2229976-21-8 |
詳細(xì)
|
| (S,R,S)-AHPC-C5-COOH |
VH032-C5-COOH |
2267282-19-7 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG2-NH2 dihydrochloride |
(S,R,S)-AHPC-PEG2-NH2二鹽酸鹽 |
2341796-76-5 |
詳細(xì)
|
| (S,R,S)-AHPC-O-Ph-PEG1-NH2 |
(2S,4R)-1-((S)-2-(2-(4-(2-氨基乙氧基)苯氧基)乙酰胺基)-3,3-二甲基丁?；?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2361117-24-8 |
詳細(xì)
|
| (S,R,S)-AHPC-C4-NH2 dihydrochloride |
(S,R,S)-AHPC-C4-氨基-二鹽酸鹽 |
2341796-78-7 |
詳細(xì)
|
| (S,R,S)-AHPC-Me-C10-NH2 |
(2S,4R)-1-((S)-2-(11-氨基十一酰胺)-3,3-二甲基丁?；?-4-羥基-N-((S)-1-(4-(4-甲基噻唑-5)-基)苯基)乙基)吡咯烷-2-甲酰胺 |
2376139-52-3 |
詳細(xì)
|
| (S,R,S)-AHPC-C10-NH2 |
VH032-C10-NH2 |
2341796-74-3 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG5-COOH |
VH 032 酰胺-PEG5-酸 |
2172820-14-1 |
詳細(xì)
|
| Thalidomide-O-amido-C4-N3 |
沙利度胺 4'-氧乙酰胺-烷基C4-疊氮化物 |
2098488-36-7 |
詳細(xì)
|
| Thalidomide-O-amido-C3-COOH |
4-(2-((2-(2,6-二氧哌啶-3-基)-1,3-二氧異吲哚啉-4-基)氧基)乙酰氨基)丁酸 |
2308035-51-8 |
詳細(xì)
|
| Thalidomide-O-amido-PEG2-C2-NH2 TFA |
沙利度胺-O-酰胺-二聚乙二醇-氨基三氟乙酸鹽 |
1957235-75-4 |
詳細(xì)
|
| E3 Ligase Ligand-Linker Conjugates 52 (TFA) |
N-(3-氨基丙基)-2-[[2-(2,6-二氧代-3-哌啶基)-1,3-二氧代-4-異吲哚啉基]氧基]乙酰胺三氟乙酸鹽 |
2022182-58-5 |
詳細(xì)
|
| Pomalidomide-PEG3-C2-NH2 |
4-((2-(2-(2-(2-氨基乙氧基)乙氧基)乙氧基)乙基)氨基)-2-(2,6-二氧代-哌啶-3-基)異吲哚-1,3-二酮 |
2093416-31-8 |
詳細(xì)
|
| Pomalidomide-C2-NH2 hydrochloride |
泊馬度胺-C2-氨基鹽酸鹽 |
2305369-00-8 |
詳細(xì)
|
| Thalidomide-O-amido-C4-NH2 hydrochloride |
薩力多胺-O-酰胺-C4-氨基鹽酸鹽 |
2245697-86-1 |
詳細(xì)
|
| Pomalidomide-PEG1-C2-N3 |
E3 ligase Ligand-Linker Conjugates 50 |
2271036-44-1 |
詳細(xì)
|
| Thalidomide-O-amido-C6-NH2 hydrochloride |
沙利度胺-氧乙酰胺-C6-氨基鹽酸鹽 |
2376990-31-5 |
詳細(xì)
|
| Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride |
薩力多胺-O-酰胺-四聚乙二醇-氨基鹽酸鹽 |
2245697-85-0 |
詳細(xì)
|
| Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride |
薩力多胺-O-酰胺-三聚乙二醇-氨基鹽酸鹽 |
2245697-84-9 |
詳細(xì)
|
| Pomalidomide-amido-PEG3-C2-NH2 |
E3 ligase Ligand-Linker Conjugates 55 |
2328070-52-4 |
詳細(xì)
|
| Thalidomide-O-amido-PEG-C2-NH2 hydrochloride |
薩力多胺-O-酰胺-一聚乙二醇-氨基鹽酸鹽 |
2204226-02-6 |
詳細(xì)
|
| Thalidomide-NH-C4-NH2 TFA |
薩力多胺-NH-C4-氨基三氟乙酸鹽 |
2093387-50-7 |
詳細(xì)
|
| Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride |
沙利度胺-O-酰胺-二聚乙二醇-氨基鹽酸鹽 |
2376990-30-4 |
詳細(xì)
|
| Thalidomide-NH-C4-NH-Boc |
泊馬度胺-NH-C4-氨基叔丁酯 |
2093388-52-2 |
詳細(xì)
|
| (S,R,S)-AHPC-Me hydrochloride |
(2S,4R)-1-[(2S)-2-氨基-3,3-二甲基丁酰]-4-羥基-N-[(1S)-1-[4-(4-甲基-1,3-噻唑-5-基)苯基]乙基]吡咯烷-2-甲酰胺鹽酸 |
1948273-03-7 |
詳細(xì)
|
| PROTAC BRD4 Degrader-5 |
|
2409538-70-9 |
詳細(xì)
|
| CCT367766 |
CCT-367766 |
2229856-58-8 |
詳細(xì)
|
| (2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylicacid |
(2S,4R)-1-((S)-2-((叔丁氧基羰基)氨基)-3,3-二甲基丁酰基)-4-羥基吡咯烷-2-甲酸 |
630421-46-4 |
詳細(xì)
|
| TD-165 |
(2S,4R)-1-((2S)-2-(11-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基)氨基)十一酰胺基)-3,3-二甲基丁?；?-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2305936-56-3 |
詳細(xì)
|
| MS1943 |
2-(氨基甲基)-1,6-二甲基-3-(苯基甲氧基)-4(1H)-吡啶酮 |
2225938-17-8 |
詳細(xì)
|
| PROTAC SGK3 degrader-1 |
SGK3 degrader-1 |
2381320-35-8 |
詳細(xì)
|
| PROTAC K-Ras Degrader-1 |
PROTAC K-RAS DEGRADER-1 |
2378258-52-5 |
詳細(xì)
|
| DT2216 |
(2S,4R)-1-((S)-2-(7-(4-((R)-3-((4-(N-(4-(4-((4'-氯-4,4-二甲基-3,4,5,6-四氫-[1,1'-聯(lián)苯]-2-基)甲基)哌嗪-1-基)苯甲?；?氨磺酰基)-2-((三氟甲基)磺?；?苯基)氨基)-4-(苯硫基)丁基)哌嗪-1-基)-7-氧代庚酰胺基)-3,3-二甲基丁?；?-4-羥基-N-((S)-1-(4-(4-甲基噻唑-5-基)苯基)乙基)吡咯烷-2-甲酰胺 |
2365172-42-3 |
詳細(xì)
|
| VH032-PEG5-C6-Cl |
1799506-06-1 |
1799506-06-1 |
詳細(xì)
|
| PROTAC FAK degrader 1 |
PROTAC FAK degrader 1 |
2301916-69-6 |
詳細(xì)
|
| INNO206 |
INNO-206 |
151038-96-9 |
詳細(xì)
|
| XZ739 |
|
2365172-19-4 |
詳細(xì)
|
| Gefitinib-based PROTAC 3 |
吉非替尼-PROTAC-3(吉非替尼雜質(zhì)54) |
2230821-27-7 |
詳細(xì)
|
| Homo-PROTAC cereblon degrader 1 |
4,4'-(((乙烷-1,2-二基雙(氧))雙(乙烷-2,1-二基))雙(氮雜二烯基))雙(2-(2,6-二氧哌啶-3-基)異吲哚-1,3-二酮) |
2244520-98-5 |
詳細(xì)
|
| Aldoxorubicin Aldoxorubicin |
(E)-N'-[1-[(2S,4S)-4-[[(2R,4S,5S,6S)-4-氨基-5-羥基-6-甲基-2-四氫吡喃基]氧基]-2,5,12-三羥基-7-甲氧基-6,11-二氧代-1,2,3,4,6,11-六氫-2-并四苯基]-2-羥基亞乙基]-6-(2,5-二氧代-2,5-二氫-1-吡咯基)己酰肼 |
1361644-26-9 |
詳細(xì)
|
| TL13-112 |
TL 13-112,ALK降解劑 |
2229037-19-6 |
詳細(xì)
|
| TL13-12 |
TL13-12 |
2229037-04-9 |
詳細(xì)
|
| UNC6852 |
|
|
詳細(xì)
|
| TL12-186 |
TL 12-186,多激酶降解PROTAC |
2250025-88-6 |
詳細(xì)
|
| MZP-54 |
MZP-54 |
2010159-47-2 |
詳細(xì)
|
| PROTAC Mcl1 degrader-1 |
PROTAC MCL1 DEGRADER-1 |
2163793-38-0 |
詳細(xì)
|
| (S,R,S)-AHPC-C6-PEG3-C4-Cl |
(S,R,S)-AHPC-C6-PEG3-丁基氯 |
1835705-55-9 |
詳細(xì)
|
| dTRIM24 |
dTRIM24 |
2170695-14-2 |
詳細(xì)
|
| (S)-2-(piperazin-2-yl)acetonitrile |
S-2-哌嗪乙腈 |
1589082-26-7 |
詳細(xì)
|
| (S,R,S)-AHPC-PEG2-C4-Cl |
(S,R,S)-AHPC-PEG2-丁基氯 |
1835705-57-1 |
詳細(xì)
|
| tert-butyl (S)-3-(cyanomethyl)piperazine-1-carboxylate |
(S)-3-(氰甲基)哌嗪-1-甲酸叔丁酯 |
1589082-06-3 |
詳細(xì)
|
| MS4077 |
MS4077 |
2230077-10-6 |
詳細(xì)
|
| β-NF-JQ1 |
化合物Β-NF-JQ1 |
2380000-55-3 |
詳細(xì)
|
| ERD-308 |
ERD-308 |
2320561-35-9 |
詳細(xì)
|
| ARD-266 |
|
|
詳細(xì)
|
| (S,R,S)-AHPC-PEG6-C4-Cl |
(S,R,S)-AHPC-2-2-2-2-2-2-6-氯 |
1835705-59-3 |
詳細(xì)
|
| PROTAC MDM2 Degrader-1 |
PROTAC MDM2 Degrader-1 |
2249944-98-5 |
詳細(xì)
|
| PROTAC ERRα Degrader-2 |
PROTAC ERRα Degrader-2 |
2306388-85-0 |
詳細(xì)
|
| AT6 |
2098836-50-9 |
2098836-50-9 |
詳細(xì)
|
| Pomalidomide-C2-NH2 |
4-((2-氨基乙基)氨基)-2-(2,6-二氧代-哌啶-3-基)異吲哚-1,3-二酮 |
1957235-66-3 |
詳細(xì)
|
| JH-XI-10-02 |
JH-XI-10-02 |
2209085-22-1 |
詳細(xì)
|
| PROTAC ER Degrader-3 |
PROTAC ER Degrader-3 |
2158322-29-1 |
詳細(xì)
|
| FKBP12 PROTAC dTAG-13 |
FKBP12 PROTAC DTAG-13 |
2064175-41-1 |
詳細(xì)
|
| PROTAC BRD4 Degrader-1 |
|
2133360-00-4 |
詳細(xì)
|
| FKBP12 PROTAC dTAG-7 |
FKBP12 PROTAC DTAG-7 |
2064175-32-0 |
詳細(xì)
|
| MRTX1257 |
2-((S)-1-丙烯酰基-4-(7-(8-甲基萘-1-基)-2-(((S)-1-甲基吡咯烷-2-基)甲氧基)-5,6,7,8-四氫吡啶并[3,4-D]嘧啶-4-基)哌嗪-2-基)乙腈 |
2206736-04-9 |
詳細(xì)
|
| Halo PROTAC 1 |
Halo PROTAC 1 |
2241668-45-9 |
詳細(xì)
|
| Homo-PROTAC pVHL30 degrader 1 |
N1,N20-雙((S)-1-((2S,4R)-4-羥基-2-((4-(4-甲基噻唑-5-基)芐基)氨基甲?；?吡咯烷-1-基)-3,3-二甲基-1-氧代丁-2-基)-3,6,9,12,15,18-六氧雜二十烷二酰胺 |
2244684-49-7 |
詳細(xì)
|
| ARCC-4 |
ARCC-4 |
1973403-00-7 |
詳細(xì)
|
| dFKBP-1 |
dFKBP-1 |
1799711-22-0 |
詳細(xì)
|
| CP-10 |
CP-10 |
2366268-80-4 |
詳細(xì)
|
| MT-802 |
2-(2-(2-(4-(4-氨基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶-1-基)哌啶-1-基)乙氧基)乙氧基) -N-(2-(2,6-氧代哌啶-3-基)-1,3-二氧代異吲哚啉-5-基)乙酰胺 |
2231744-29-7 |
詳細(xì)
|
| BI-3663 |
BI-3663 |
2341740-84-7 |
詳細(xì)
|
| ACBI1 |
ACBI1 |
2375564-55-7 |
詳細(xì)
|
| PROTAC KRASG12C Degrader-LC-2 |
(2S,4R)-1-((S)-2-(3-(3-((S)-2-(((7-(8-氯萘-1-基)-4-((S)-3-(氰基甲基)-4-(2-氟丙烯?；?哌嗪-1-基)-5,6,7,8-四氫吡啶并[3,4-D]嘧啶-2-基)氧基)甲基)吡咯烷-1-基)丙氧基)丙酰胺基)-3,3-二甲基丁酰基)-4-羥基-N-(4-(4-甲基噻唑-5-基)芐基)吡咯烷-2-甲酰胺 |
2502156-03-6 |
詳細(xì)
|
| NEDISERTIB |
(αS)-α-[2-氯-4-氟-5-[7-(4-嗎啉基)-4-喹唑啉基]苯基]-6-甲氧基-3-噠嗪甲醇 |
1637542-33-6 |
詳細(xì)
|
| BETd-260 |
4-[(3-環(huán)丙基-1-乙基-1H-吡唑-5-基)氨基]-7-(3,5-二甲基-4-異惡唑基)-N-[5-[2-(2,6-二氧代-3-哌啶基)-2,3-二氫-1-氧代-1H-異吲哚-4-基]戊基]-6-甲氧基-9H-嘧啶并[4,5-B]吲哚-2-甲酰胺 |
2093388-62-4 |
詳細(xì)
|
| BETd-246 |
BETD-246 |
2140289-17-2 |
詳細(xì)
|
| MZP-55 |
2010159-48-3 |
2010159-48-3 |
詳細(xì)
|
| (R)-2-(piperazin-2-yl)acetonitrile dihydrochloride |
2-[(2R)-哌嗪-2-基]乙腈二鹽酸鹽 |
2250242-66-9 |
詳細(xì)
|
| PROTAC Bcl2 degrader-1 |
PROTAC Bcl2 degrader-1 |
2378801-85-3 |
詳細(xì)
|
| PROTAC BRD4 Degrader-2 |
|
2185795-53-1 |
詳細(xì)
|
| PROTAC IRAK4 degrader-1 |
PROTAC IRAK4 degrader-1 |
2360533-90-8 |
詳細(xì)
|
| PROTAC CRBN Degrader-1 |
PROTAC CRBN Degrader-1 |
2358775-70-7 |
詳細(xì)
|
| PROTAC FLT-3 degrader 1 |
PROTAC FLT-3 DEGRADER 1 |
2230826-81-8 |
詳細(xì)
|
| dMCL1-2 |
dMCL1-2 |
2351218-88-5 |
詳細(xì)
|
| PROTAC BRD4 Degrader-3 |
GNE-987 |
2313234-00-1 |
詳細(xì)
|
| BAY-1797 |
N-(4-(3-氯苯氧基)-3-氨磺?；交?-2-苯基乙酰胺 |
2055602-83-8 |
詳細(xì)
|
| FKBP12 PROTAC RC32 |
RC32 |
2375555-66-9 |
詳細(xì)
|
| PROTAC ERRα Degrader-1 |
PROTAC ERRα Degrader-1 |
2306388-84-9 |
詳細(xì)
|
| 1-Piperazinecarboxylic acid, 2-(cyanomethyl)-4-[5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, 1,1-dimethylethyl ester, (2S)- |
1-Piperazinecarboxylic acid, 2-(cyanomethyl)-4-[5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-, 1,1-dimethylethyl ester, (2S)- |
2206737-05-3 |
詳細(xì)
|
| (2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)amino]acetic acid |
2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代異吲哚啉-4-基)氨基)乙酸 |
927670-97-1 |
詳細(xì)
|
| PROTAC CDK2/9 Degrader-1 |
|
2408641-24-5 |
詳細(xì)
|
| PROTAC ER Degrader-4 |
PROTAC ER Degrader-4 |
2361114-15-8 |
詳細(xì)
|
| PROTAC FKBP Degrader-3 |
PROTAC FKBP Degrader-3 |
2079056-43-0 |
詳細(xì)
|
| AZ20 |
4-[4-[(3R)-3-甲基-4-嗎啉基]-6-[1-(甲基磺酰基)環(huán)丙基]-2-嘧啶基]-1H-吲哚 |
1233339-22-4 |
詳細(xì)
|